TurnerTrends Stock Rating Report for ASTM
Data valid for week beginning July 14, 2008
|
ASTM [News]
|
Aastrom Biosciences Inc
|
Company Profile
"Aastrom Biosciences, Inc. operates as a regenerative medicine company, focusing on the clinical development of autologous cell products for the repair or regeneration of multiple human tissues, based on its proprietary Tissue Repair Cell (TRC) technology. The company's TRC technology is based on its cell products, which are a unique cell mixture containing large numbers of stem and progenitor cells, produced outside of the body from a small amount of bone marrow taken from the patient, and the means to produce these products in an automated process. Its TRC-based products are being clinically evaluated for bone regeneration to treat osteonecrosis of the femoral head, which is in ON-CORE Phase III trial in the United States and in pivotal trial in Spain- and vascular regeneration in patients with critical limb ischemia that is in RESTORE-CLI Phase IIb trial in the United States and in Phase I-II trial in Germany. In addition, Aastrom Biosciences has completed a U.S. Phase I-II severe non-union fracture clinical trial, and is also developing programs to address cardiac and neural regeneration indications. TRC-based products have received Orphan Drug Designation from the Food and Drug Administration for use in the treatment of osteonecrosis of the femoral head and the treatment of dilated cardiomyopathy, a severe chronic heart disease. Aastrom Biosciences was founded in 1989 and is headquartered in Ann Arbor, Michigan."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Thu, 19 Jun 2008 11:45:19 Etc/GMT | Aastrom Biosciences downgraded by Dawson James (Briefing.com) | | Wed, 18 Jun 2008 20:02:38 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta (EDGAR Online) | | Wed, 18 Jun 2008 20:00:00 Etc/GMT | Aastrom Biosciences Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule (PrimeNewswire) | | Tue, 17 Jun 2008 12:30:00 Etc/GMT | Aastrom to Initiate Phase II Clinical Trial Using Cardiac Repair Cells Derived From Patient's Own Bone Marrow for Treatment of Severe Chronic Heart Failure (PrimeNewswire) | | Sun, 1 Jun 2008 15:26:18 Etc/GMT | 10 Biotechs in Stem Cells that Could Profit Under the Democrats (at Seeking Alpha) | | Tue, 20 May 2008 13:35:30 Etc/GMT | AASTROM BIOSCIENCES INC Financials (EDGAR Online Financials) | | Tue, 13 May 2008 14:52:01 Etc/GMT | New Star Analyst Rankings for AASTROM BIOSCIENCE (StarMine) | | Mon, 12 May 2008 20:08:22 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition (EDGAR Online) | | Mon, 12 May 2008 20:05:10 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report (EDGAR Online) | | Mon, 12 May 2008 20:00:00 Etc/GMT | Aastrom Reports Third Quarter Fiscal Year 2008 Financial Results (PrimeNewswire) | | Mon, 12 May 2008 11:07:33 Etc/GMT | Q3 2008 Aastrom Biosciences Earnings Release - Time Not Supplied (CCBN) | | Thu, 8 May 2008 18:30:00 Etc/GMT | Webcast Alert: Aastrom Announces Third Quarter Investor Conference Call (Business Wire) | | Mon, 5 May 2008 20:32:07 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Mon, 5 May 2008 20:30:10 Etc/GMT | Aastrom Biosciences Board of Directors Withdraws Reverse Stock Split Proposal (PrimeNewswire) | | Wed, 23 Apr 2008 17:15:00 Etc/GMT | Aastrom Event Reminder: Q&A Sessions Regarding Shareholder Proposal (PrimeNewswire) | | Thu, 17 Apr 2008 16:01:14 Etc/GMT | Encouraging Clinical Data Reported From Aastrom's First EU Compassionate Use Cardiac Patients (PrimeNewswire) | | Tue, 8 Apr 2008 19:30:00 Etc/GMT | Aastrom Biosciences Adjourns Special Meeting Until May 6, 2008; Board Urges Shareholders to Vote for the Proposal Considered Critical to the Future of the Company (PrimeNewswire) | | Tue, 8 Apr 2008 19:26:42 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (EDGAR Online) | | Fri, 14 Mar 2008 19:02:36 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princi (EDGAR Online) | | Fri, 22 Feb 2008 21:02:34 Etc/GMT | AASTROM BIOSCIENCES INC Files SEC form 8-K, Other Events (EDGAR Online) | News provided by Yahoo! Finance |
|
